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Abstract 
Retinoic acid receptor (RAR) signaling regulates bone structure and hematopoiesis through 
intrinsic and extrinsic mechanisms. This study aimed to establish how early in the osteoblast 
lineage loss of Rarg disrupts the bone marrow microenvironment. Bone structure was analyzed 
by microCT in Rarg-/- mice and mice with Rarg conditional deletion in Osterix-Cre-targeted 
osteoblast progenitors or Prrx1-Cre-targeted mesenchymal stem cells. Rarg-/- tibiae exhibited 
less trabecular and cortical bone and impaired longitudinal and radial growth. The trabecular 
bone and longitudinal, but not radial, growth defects were recapitulated in Prrx1:RargΔ/Δ mice 
but not Osx1:RargΔ/Δ mice. While both male and female Prrx1:RargΔ/Δ mice had low trabecular 
bone mass, males exhibited increased numbers of trabecular osteoclasts and Prrx1:RargΔ/Δ 
females had impaired mineral deposition. Both male and female Prrx1:RargΔ/Δ growth plates 
were narrower than controls and their epiphyses contained hypertrophic chondrocyte islands. 
Flow cytometry revealed that male Prrx1:RargΔ/Δ bone marrow exhibited elevated pro-B and 
pre-B lymphocyte numbers, accompanied by increased Cxcl12 expression in bone marrow 
cells. Prrx1:RargΔ/Δ bone marrow also had elevated megakaryocyte-derived Vegfa expression 
accompanied by smaller sinusoidal vessels. Thus, RARγ expression by Prrx1-Cre-targeted 
cells directly regulates endochondral bone formation and indirectly regulates tibial 
vascularization. Furthermore, RARγ expression by Prrx1-Cre-targeted cells extrinsically 
regulates osteoclastogenesis and B lymphopoiesis in male mice.  
Keywords: Genetic animal models, osteoimmunology, osteoblasts, stromal/stem cells, tissue 
signaling – other (retinoic acid receptor signaling) 
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Introduction 
The skeleton is a dynamic organ that is constantly remodeled to maintain its structural integrity. 
The medullary cavity of bones contains bone marrow (BM), which is the primary post-natal 
site of hematopoiesis. Microenvironments in the BM are comprised of multiple cell types that 
influence each other to regulate both hematopoiesis and bone formation and resorption. These 
cell types include mesenchymal stem cells, osteoblast-lineage cells, perivascular cells, 
endothelial cells, adipocytes and hematopoietic cells including osteoclasts and immune cells. 
Previous studies have found that deletion of retinoic acid receptor γ (RARγ) resulted in mice 
with low bone mass and hematopoietic defects that were, at least in part, induced by non-
hematopoietic cells (1, 2). Thus, while RARγ has direct roles in hematopoiesis (intrinsic 
regulation), RARγ signaling in non-hematopoietic cells in the BM microenvironment also 
influences hematopoiesis (extrinsic regulation). 
RARs are nuclear receptors that regulate transcription of genes and have important roles in the 
proliferation and differentiation of many cell lineages. There are three subtypes of RARs; α, β 
and γ, that can have either distinct or equivalent functions in different cell lineages (3). Rara-/- 
and Rarg-/- mice have defects in multiple tissues and were initially reported to exhibit neonatal 
lethality (4, 5). The housing of these mice in a clean animal facility improved survival, 
especially for Rara-/- mice. While Rarg-/- mice still showed significant post-natal lethality in 
cleaner housing conditions, some survived up to 12 months of age (6). Eight-week-old Rara-/- 
mice displayed no defects in bone (1) or hematopoiesis (6, 7). In comparison, 
histomorphometric analysis of tibiae from 8-week-old Rarg-/- mice revealed they had less 
trabecular bone when compared to wild type littermates, and in males this was associated with 
increased osteoclastogenesis (1).  
In addition to lower bone mass, Rarg-/- mice developed a myeloproliferative-like syndrome 
(MPS) characterized by significantly more granulocytes in the peripheral blood (PB), BM and 
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spleen (2). Rarg-/- mice also exhibited defects in erythropoiesis and B lymphopoiesis (2, 8), 
with lower numbers of pro-B and pre-B lymphocytes in the BM (9). When BM from wild type 
mice was transplanted into mice with a Rarg-/- microenvironment, the transplanted mice rapidly 
developed the MPS-like disease and the erythrocyte and B lymphocyte defects. In comparison, 
when Rarg-/- BM was transplanted into wild type mice these hematopoietic defects were 
resolved. This indicated that RARγ expression in microenvironment cells (extrinsic) was 
essential for normal hematopoiesis, and that the mature hematopoietic cell defects observed in 
Rarg-/- mice were not due to intrinsic loss of RARγ in those cells. 
We have recently shown that deletion of Rarg in primitive nestin-Cre-targeted neural crest-
derived mesenchymal stem cells (MSCs) and their progeny impaired BM B lymphopoiesis and 
thymic T lymphopoiesis (9). The defects observed in nestin-Cre:RargΔ/Δ mice did not fully 
recapitulate all hematopoietic phenotypes exhibited by Rarg-/- mice, suggesting that additional 
cells within the microenvironment regulate hematopoiesis via the actions of RARγ. Since 
osteoblast-lineage cells play a key role in supporting B lymphopoiesis (10-12), and Rarg is 
expressed throughout osteoblast differentiation (13), we sought to investigate the role of RARγ 
at different stages of osteoblast commitment in the regulation of bone structure and 
hematopoiesis. 
To determine whether committed osteoblast-lineage cells were involved in inducing changes 
to bone mass and hematopoiesis we conditionally deleted Rarg in osteoblast progenitors (OPs) 
and their progeny using Osx1-Cre and compared their phenotype to mice with targeted deletion 
in more primitive limb bud-derived MSCs and their progeny using Prrx1-Cre (also known as 
Prx1). Here we report a role for Rarg signaling in Prrx1-Cre-targeted limb bud-derived 
mesenchymal cells, but not in Osx1-Cre-targeted osteoprogenitor cells, in the regulation of 
endochondral bone, sinusoidal vessels and B lymphopoiesis.  
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Methods 
Mice 
All experiments were approved by the St. Vincent's Health Melbourne Animal Ethics 
Committee and conducted in strict compliance to the regulatory standards of the Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes. Tibiae were obtained 
from 8- and 12-week-old male and female Rarg-/- [Rargtm1Ipc] and Rarg+/+ littermate mice (4). 
Rarg was conditionally deleted in OPs using Osx1-GFP::Cre [B6.Cg-Tg(Sp7-tTA,tetO-
EGFP/cre)1Amc/J] (14) and in limb bud-derived mesenchymal stem cells using Prrx1-Cre 
mice [B6.Cg-Tg(Prrx1-cre)1Cjt/J] (15), each of these crossed with Rargfl/fl mice [Rargtm3Ipc] 
(16). In all studies 12-week-old Cre+:Rarg+/+ mice were used as controls for 12-week-old 
Cre+:Rargfl/fl mice. Osx1-GFP::Cre+Rargfl/fl mice are referred to as Osx1:RargΔ/Δ, Osx1-
GFP::Cre+Rarg+/+ as Osx1:Rarg+/+, Prrx1-Cre+:Rargfl/fl as Prrx1:RargΔ/Δ and Prrx1-
Cre+:Rarg+/+ as Prrx1:Rarg+/+. All mice were fully backcrossed onto the C57BL/6 strain prior 
to use in these studies. Prrx1:Rarg mice were crossed with Rosa26-loxP-stop-loxP-enhanced 
yellow fluorescent protein (R26-stop-EYFP; B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J) mice for 
these studies. Prrx1-Cre mice occasionally exhibit germline activation of Cre (15). To exclude 
these mice from analysis germline activation was identified by EYFP expression in peripheral 
blood (PB) cells by flow cytometry for all Prrx1-Cre+ mice. In Prrx1:RargΔ/Δ mice, excision 
of Rarg exon 8 was also confirmed to be specific to non-hematopoietic tissues by genomic 
PCR of PB (forward primer: tcttacctgctgagtcccaaccaa, reverse primer: 
agaagaaagcagttacagggcagg). 
 
Micro-computed tomography 
Bone structure of tibiae from 8-week-old Rarg mice [to compare to previous work (1)] and 
adult 12-week-old Rarg,  Osx1:Rarg and Prrx1:Rarg mice were analysed by µCT. Tibiae were 
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dissected, cleaned of muscle and connective tissue, fixed in 2% paraformaldehyde overnight 
at 4°C then stored in 70% ethanol. The SkySkan 1076 system (Bruker-microCT, Kontich, 
Belgium) was used to scan tibiae, following standard guidelines (17). The image acquisition 
parameters used were: 9 µm voxel resolution, 0.5 mm aluminum filter, 45 kV voltage and 100 
µA current, 2300 ms exposure time, 0.5¡ rotation step and frame averaging of 1. Reconstruction 
and analysis of images was performed using SkyScan software NRecon (1.6.9.8), DataViewer 
(1.5.0) and CTAnalyser (1.13.11.0). The region of interest (ROI) for tibial trabecular bone was 
identified as a 3% distal offset from the growth plate and a height of 13.5% of total tibial length. 
Trabecular bone was analyzed utilizing adaptive thresholding for all samples; minimum values 
were 45 (Rarg), 44 (Osx1:Rarg), 51 (Prrx1:Rarg) and maximum of 225. Region of interests 
for cortical bone were defined as a 40% distal offset from the growth plate and 13.5% region 
of total tibial length. Global automatic thresholding was used for cortical bone analysis with a 
minimum of 95 (Rarg, Osx1:Rarg) or 100 (Prrx1:Rarg) and a maximum of 225.  
 
Histomorphometry, immunohistochemistry and immunofluorescence 
Tibiae were embedded in methylmethacrylate and 5 µm sections were stained with toluidine 
blue as previously described (1, 18). Histomorphometry of the secondary spongiosa was 
performed using OsteoMeasure7 v4.1.1.2 (OsteoMetrics, Atlanta, GA, USA) using standard 
guidelines (19). The region analyzed was 370 µm distal to the base of the growth plate using a 
370 µm2 box from the edge of the marrow cavity excluding all cortical bone in 3 non-
overlapping rows. 
Cartilage and sinusoidal vessels were analyzed on decalcified tibial sections as previously 
described (20). Tibiae were fixed in 2% paraformaldehyde overnight, decalcified by replacing 
the EDTA solution twice over 2 weeks. Samples were processed and embedded in paraffin, 
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5µm sections were dewaxed and rehydrated. To analyze sinusoidal vessels, samples were 
stained for VEGFR-3 (eBioscience) at [1:400] as previously described (20). To analyze the 
growth plate, samples were stained with Safranin-O and Fast Green as previously described 
(21). The numbers and sizes of VEGFR-3+ sinusoidal vessels and sinusoid perimeter in the 
secondary spongiosa, in addition to growth plate height and the number of epiphyseal 
hypertrophic chondrocyte islands were measured using OsteoMeasure software (20). The 
growth plate proliferative versus hypertrophic zones could not be distinguished, so separate 
samples were collected at 20 days of age to allow assessment of these zones according to 
standard protocols using OsteoMeasure software (22). 
Mouse tibiae were prepared following the protocol described by Poulton et al. (23, 24). 
Immunofluorescence labelling protocol for formalin-fixed, paraffin-embedded tissue was 
adapted from Nolan et al. (25). Antibodies, detection and labelling conditions are found in 
Supplemental Table 2. Endogenous peroxidase activity was blocked with 3% H2O2 (Merck, 
MA, USA) for 30 mins, washed in Tris-buffered saline (TBS), followed by a protein block 
with TNB blocking solution (Perkin Elmer, MA, USA) for 1 hour prior to primary antibody 
incubation (Supplemental Table 2). All washes were performed three times with TBS for 5 
mins each. Multiplexed immunofluorescence labelling was done through sequential staining as 
described previously (24). After antibody staining, sections were counterstained with DAPI 
(1:1000) for 5 mins and mounted in Citifluor hard set mounting media CFPVOH plus AF100 
(Citifluor, PA, USA). Whole slide scans were imaged on the Vectra Polaris Quantitative 
Pathology Imaging System (Perkin Elmer). 
  
Hematological analysis 
PB was obtained by retro-orbital bleeding, BM was flushed from one femur, spleens were 
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crushed and filtered to single cell suspensions. Hematopoietic cellularity was assessed with a 
Sysmex KX-21N analyzer (Sysmex, Kobe, Japan). BM cells were stained with fluorophore-
conjugated antibodies (Supplementary Table 1) (26), all flow cytometry data were collected 
using a Becton Dickinson (BD) LSR Fortessa (BD Bioscience) and data analyzed using FlowJo 
8.8.7 (Treestar, Ashland, OR, USA). 
 
Analysis of primary osteoblast-lineage cells 
Osteoblast-lineage cells were isolated from Prrx1:Rarg long bones as previously described 
(13). Briefly, bones were cleaned, cut into 1 mm2 pieces and gently crushed using a mortar and 
pestle. Bone marrow was removed by washing fragments with 2% FBS and 5 mM EDTA in 
PBS. Bone fragments (containing trabecular and cortical bone) were digested with 3 mg/ml 
collagenase type 1 (Worthington) in PBS for 45 minutes at 37°C with agitation and stained 
with fluorophore-conjugated antibodies (Supplementary Table 1). Non-viable, hematopoietic 
(CD45, Ter119) and endothelial (CD31) cells were omitted, MSCs (Sca-1+, CD51+) and 
osteoblast-lineage cells (Sca-1-, CD51+) were sorted on a BD Influx (BD Bioscience) (13).  
 
RNA isolation and qPCR 
Total RNA was isolated using an Isolate II RNA Micro Kit (Bioline) and cDNA synthesized 
using AffinityScript qPCR cDNA Synthesis Kit (Agilent Technologies, Santa Clare, CA, USA) 
as per manufacturers’ instructions. qPCR was performed using Brilliant II SYBR green 
(Agilent Technologies) and 5 pmol of primers [all reported previously (1, 26, 27)] using a 
MxPro 3000P Stratagene system and software.  
 
Statistics 
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Data are presented as mean ± SD and statistical analysis was performed using an unpaired two-
tailed Student’s t-test in Prism 7 (Graphpad Software, La Jolla, CA, USA).   
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Results 
Rarg-/- mice have less trabecular bone 
MicroCT analysis of 8- and 12-week-old Rarg mice confirmed the findings of our previous 
study that used histomorphometric analysis (1). In 8- and 12-week-old Rarg-/- tibiae, trabecular 
bone volume was 72% and 62% lower in males and 42% and 58% lower in females compared 
to Rarg+/+ mice (Fig. 1 and Supplemental Fig. 1 show 12- and 8-week-old data, respectively). 
There were no changes in trabecular thickness in Rarg-/- mice (Fig. 1B, Supplemental Fig 1B). 
However, trabecular separation was significantly higher (Fig. 1C, Supplemental Fig. 1C) and 
trabecular number was significantly lower in both male and female Rarg-/- mice compared to 
their sex-matched controls (Fig. 1D, Supplemental Fig. 1D). The lower trabecular bone mass 
in Rarg-/- mice is shown in reconstructed images of 3D trabecular bone stucture (Fig. 1E-H, 
Supplemental Fig. 1E-H).  
 
Rarg-/- mice have impaired bone growth 
Tibiae of 8- and 12-week-old Rarg-/- mice were >12% shorter compared to Rarg+/+ mice 
(Supplemental Fig. 1I, Fig. 1I), indicating impaired longitudinal growth of tibiae. µCT analysis 
found no change in cortical bone parameters in 8-week-old female mice, consistent with our 
previous histomorphometric analysis (1) (Supplemental Fig. 1J-M). However, 8-week-old 
male and all 12-week-old Rarg-/- mice had thinner cortical bone compared to Rarg+/+ mice 
(Supplemental Fig. 1J, Fig. 2A). These mice also had a significantly smaller cortical area and 
periosteal perimeter (Supplemental Fig. 1L-M, Fig. 2C-D), indicating impaired radial growth. 
12-week old Rarg-/- females also had a greater marrow area (Fig. 2B).   
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Osx1:RargΔ/Δ mice have no change in bone volume 
We next sought to identify which osteoblast precursor population is important for maintaining 
trabecular and cortical bone mass via RARγ signaling. Rarg-/- male mice exhibited increased 
osteoclastogenesis in vivo, yet RAR inhibition blocked osteoclast differentiation of mouse 
whole BM cells and RAW264.7 cells in vitro (1). Osteoclast formation is commonly regulated 
by osteoblast-lineage cells via their production of RANKL and OPG (28), therefore we 
investigated the bone phenotype in mice with Rarg deletion in the osteoblast lineage, directed 
with Osx1-Cre. Analysis of 12-week-old male tibiae by µCT found no changes in trabecular 
bone structure in the secondary spongiosa (Fig. 3A-F). Analysis of cortical bone similarly 
identified no significant differences between Osx1:RargΔ/Δ and Osx1:Rarg+/+ mice and tibial 
length was unchanged by Rarg targeting (Supplemental Fig. 2A-G). Hence loss of Rarg from 
Osx1-Cre-targeted OPs and their progeny is not the cause of the bone defects observed in Rarg-
/- mice.  
 
Prrx1:RargΔ/Δ mice have reduced trabecular bone  
We deleted Rarg in primitive limb bud-derived mesenchymal stem cells and their progeny 
using Prrx1-Cre to determine if an earlier mesenchymal cell might mediate the impaired bone 
growth and lower trabecular bone mass observed with global loss of Rarg. Prrx1:RargΔ/Δ male 
and female mice had significantly less trabecular bone compared to age- and sex-matched 
Prrx1:Rarg+/+ mice (Fig. 4A, E-H). Trabecular thickness was unchanged (Fig. 4B) but 
Prrx1:RargΔ/Δ males had significantly greater trabecular separation (Fig. 4C) and both male 
and female Prrx1:RargΔ/Δ mice had lower trabecular number than controls (Fig. 4D). These 
changes to trabecular bone mimicked those observed in Rarg-/- mice, although the difference 
in bone mass was more variable in males. The low trabecular bone mass was more pronounced 
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in Prrx1:RargΔ/Δ males than females, consistent with observations in Rarg-/- mice [(1) and Fig. 
1]. The tibiae were shorter in Prrx1:RargΔ/Δ compared to Prrx1:Rarg+/+ mice (Fig. 4I), 
however, no differences in cortical bone structure were observed between Prrx1:RargΔ/Δ and 
Prrx1:Rarg+/+ mice (Supplemental Fig. 3), indicating that longitudinal, but not radial, growth 
was impaired. 
 
Prrx1:RargΔ/Δ females exhibit more trabecular osteoblasts and males have more trabecular 
osteoclasts 
In female Prrx1:RargΔ/Δ mice, histomorphometric analysis revealed that the low bone volume 
was accompanied by a greater proportion of unmineralized bone (osteoid) in the trabecular 
bone (Fig. 5A). Female Prrx1:RargΔ/Δ mice had a significantly higher percentage of bone 
comprising osteoid due to a greater proportion of osteoid-covered bone surface (Fig. 5A-B) 
rather than a significant change in osteoid thickness (Fig. 5C). Female Prrx1:RargΔ/Δ mice also 
had more osteoblasts than controls (Fig. 5E), and although most Prrx1:RargΔ/Δ females had a 
higher osteoblast surface this was not statistically significant (Fig. 5D).  
In contrast to female mice, male Prrx1:RargΔ/Δ mice displayed no significant changes in 
trabecular osteoid surface, osteoblast numbers or osteoblast surface compared to age-matched 
Prrx1:Rarg+/+ mice (Fig. 5A-E). Instead, male Prrx1:RargΔ/Δ mice exhibited greater osteoclast 
surface and osteoclast numbers in trabecular bone compared to Prrx1:Rarg+/+ males (Fig. 5F-
G). These data have revealed that Rarg deletion in very primitive cells of the osteoblast lineage 
is the major contributor to the bone phenotype in Rarg-/- mice and that the cellular mechanisms 
by which RARγ regulates trabecular bone mass are either different in males and females or 
predominate to different extents in males and females. 
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Further investigation of tibial sections revealed islands of hypertrophic chondrocytes in the 
epiphyseal trabecular bone of both male and female Prrx1:RargΔ/Δ mice (Fig. 5H-K). When 
quantified, chondrocyte islands were present in the majority of Prrx1:RargΔ/Δ mice but only in 
one Prrx1:Rarg+/+ male mouse. This suggests their impaired growth relates to a delay in 
establishment of the secondary ossification center. Furthermore, the growth plates of 
Prrx1:RargΔ/Δ male and female mice were 14.8% and 16.3% shorter than controls (Fig. 5L), 
respectively, correlating with the impaired bone growth in these mice and the high level of 
RARγ expression in the murine growth plate (29).  Surprisingly, when the growth plates of 
young (20 day old) Prrx1:RargΔ/Δ male and female mice were assessed, this difference in 
growth plate width was not present, but the proliferative zone (Fig. 5M) was of normal width 
and the hypertrophic zone width was extended (Fig. 5N). The hypertrophic chondrocytes also 
appeared larger in size (Fig. 5O, P). This suggested that both the reduction in bone length, and 
the presence of cartilage islands within the secondary ossification center may relate to an 
extension in the period of hypertrophy. This was clearly transient, and was followed by an early 
reduction in growth plate width.  
 
Prrx1:RargΔ/Δ male mice demonstrated altered bone marrow B lymphopoiesis 
We sought to determine whether Prrx1:RargΔ/Δ mice also had microenvironment-induced 
alterations in hematopoietic cells. Hematological analysis revealed that Prrx1:RargΔ/Δ males, 
but not females, exhibited a significant increase in BM leukocytes (Fig. 6A). To further 
investigate the altered leukocyte numbers in Prrx1:RargΔ/Δ males, BM samples were profiled 
by flow cytometry (Fig. 6B-C). In Prrx1:RargΔ/Δ males there was a significant increase in the 
numbers of BM-derived B220+IgM- cells, with no changes in the numbers of B220+IgM+ B 
lymphocytes (identifying a mix of BM-derived immature B lymphocytes and recirculating 
mature B lymphocytes) (Fig. 6D). Further investigation revealed that within the B220+IgM- 
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population (Fig. 6C) there was an increase in the numbers of both CD19+CD43+ pro-B 
lymphocytes and CD19+CD43- pre-B lymphocytes, but no change in the numbers of CD19-
CD43+ pre-pro-B lymphocytes in Prrx1:RargΔ/Δ compared to Prrx1:Rarg+/+ male mice (Fig. 
6E). Thus the enhanced formation of early B lymphocyte precursors originated at the pro-B 
lymphocyte stage but did not affect maturing (B220+IgM+) B lymphocyte numbers (Fig. 6F). 
The hematopoietic phenotype was sex-specific as there were no changes in BM B lymphocytes 
in female Prrx1:RargΔ/Δ mice (Supplemental Fig. 4). We also confirmed that Prrx1-Cre did 
not target the B lymphocytes, with no co-expression of B220 and EYFP observed in 
immunofluorescence studies of tibiae or flow cytometry analysis of the peripheral blood of the 
mice (Supplemental Fig. 5). Furthermore, there were no differences in the numbers of PB 
(Supplemental Fig. 4) or splenic (data not shown) B lymphocytes in male or female 
Prrx1:RargΔ/Δ mice. Aside from an increase in BM granulocytes in female Prrx1:RargΔ/Δ mice, 
no other significant differences were detected in the other hematopoietic cell populations (data 
not shown). 
Our data suggested that Prrx1-Cre targets cells that are involved in the regulation of B 
lymphopoiesis, thus we investigated the gene expression of key factors involved in this process 
(30, 31) in whole BM cells. The expression of Cxcl12, tumor necrosis factor receptor 
superfamily member 11b (Tnfrsf11b; OPG) and Vegfa were significantly higher in 
Prrx1:RargΔ/Δ mice, Flt3l was unchanged (Fig. 6G-J) and Tnfsf11 (RANKL), Kitl and Il7 could 
not be detected. To determine if mesenchymal cells were the sources of the altered transcripts, 
osteoblastic cells were purified by FACS into Prrx1:EYFP+ MSCs (lineage, CD45 and CD31 
negative, Sca-1+, CD51+) and osteoblast-lineage cells (lineage, CD45 and CD31 negative, Sca-
1-, CD51+) from Prrx1:Rarg+/+ and Prrx1:RargΔ/Δ mice. qPCR revealed different changes in 
gene expression in purified Prrx1:RargΔ/Δ osteoblastic populations compared to whole BM 
cells. The expression of Cxcl12, the secreted and membrane forms of Kit ligand (Kitl) and Flt3l 
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were significantly lower in Prrx1:RargΔ/Δ MSCs compared to Prrx1:Rarg+/+ MSCs (Fig. 6K). 
All other transcripts were unaltered in MSCs (Fig. 6K), with the exception of Il7 and Tnfsf11, 
which were not detected. Furthermore, Cxcl12, secreted Kitl and Il7 were significantly reduced 
in Prrx1:RargΔ/Δ osteoblast-lineage cells whereas all other transcripts were unaltered (Fig. 6L), 
with the exception of Tnfsf11 which could not be detected (data not shown).  
 
Prrx1:RargΔ/Δ mice altered bone marrow vascularization 
Endochondral bone formation is tightly linked to BM angiogenesis and sinusoidal vessels are 
important constituents of the BM microenvironment. Given that Vegfa expression was 
increased in the BM of Prrx1:RargΔ/Δ mice and is a key regulator of BM angiogenesis, we 
quantified the numbers of sinusoidal vessels in the BM of the secondary spongiosa by 
histomorphometry. The number of sinusoids in the BM was increased in Prrx1:RargΔ/Δ females 
(Fig. 7A, G-H). In both male and female Prrx1:RargΔ/Δ mice the sinusoids were smaller (Fig. 
7B, E-H). The sinusoids occupied less space within the BM in male Prrx1:RargΔ/Δ mice (Fig. 
7B-C), reflecting the sinusoidal vessel constriction. In contrast, the sinusoid perimeter per 
marrow area was unchanged (Fig. 7D). The vessel phenotype was reflected throughout the BM 
including in the primary spongiosa (data not shown). 
To determine the source of the increased Vegfa observed in the BM we performed 
immunofluorescence studies, investigating the co-expression of the Prrx1-Cre-targeted cells 
(using an antibody against EYFP), and Vegf-a in tibiae sections from Prrx1:RargΔ/Δ and 
Prrx1:Rarg+/+ mice. Vegf-a was highly expressed in the growth plate of Prrx1:Rarg+/+ mice 
(Fig. 7I), consistent with a previous report showing Vegf-a expression in this region (32). In 
contrast, the production of Vegf-a was significantly reduced in the growth plate of 
Prrx1:RargΔ/Δ mice, but increased in the bone marrow megakaryocytes (Fig. 7J). Flow 
cytometry-based quantitation studies showed that the proportions of CD41+ megakaryocytes 
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were unaltered in the bone marrow of Prrx1:RargΔ/Δ compared to Prrx1:Rarg+/+ mice (Fig. 
7K). 
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Discussion 
This study has identified that RARγ activity in Prrx1-Cre-targeted cells is a key regulator in 
the formation of a healthy BM microenvironment, significantly influencing the development 
of normal trabecular bone mass, angiogenesis and B lymphopoiesis.  
Loss of Rarg in Prrx1-Cre-targeted cells and their progeny resulted in similar (albeit less 
severe) changes to trabecular bone and longitudinal bone growth as Rarg-/- mice. The bone 
phenotypes were not observed when Rarg was deleted in Osx1-Cre-targeted early osteoblast 
progenitor cells (and also a subset of hypertrophic chondrocytes), confirming that this role of 
Rarg is mediated by a non-overlapping population of immature mesenchymal cells targeted by 
Prrx1-Cre. Deletion of Rarg in Prrx1-Cre-targeted cells also influenced growth plate 
chondrocyte hypertrophy preceding the trabecular bone defects and abnormal BM 
vascularization in Prrx1:RargΔ/Δ mice.  
Prrx1:RargΔ/Δ, but not Osx1:RargΔ/Δ, mice had defects in trabecular bone mass, similar to that 
observed in Rarg-/- mice. Prrx1-Cre and Osx1-Cre both target cells that give rise to the 
osteoblast lineage, however their expression patterns vary between anatomical sites and the 
other mesenchymal lineages they form. In Prrx1-Cre mice, Cre recombinase (Cre) is expressed 
in the multipotent cells of the limb bud mesenchyme, flank mesoderm and craniofacial 
mesenchyme, i.e. in the appendicular skeleton, some calvarial bones and the sternum but not 
in the vertebrae (15). This means that genes deleted from Prrx1-Cre+ multipotent cells will 
remain deleted in their progeny. In the BM of long bones, 50% of Prrx1-Cre+ cells are 
PDGFRa+Sca-1+ (PaS) cells (a population enriched with MSCs) and Prrx1-Cre+ cells give 
rise to osteoblasts/osteocytes, CXCL12-abundant reticular (CAR) cells, adipocytes and 
chondrocytes, but not hematopoietic or endothelial cells (33, 34). Thus, the changes observed 
in Prrx1:RargΔ/Δ bones could be due to loss of Rarg in any of these cell types or combinations 
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of cells. In comparison, Osx1-Cre only targets a small proportion of PaS cells (~5%) (33) and 
is expressed in more differentiated early OPs that give rise to osteoblasts residing in the 
perichondrium, periosteum, endosteum and trabecular bone as well as osteocytes (14, 35, 36). 
In addition to the osteoblast lineage, Osx1-Cre is expressed in some growth plate 
prehypertrophic and hypertrophic chondrocytes, perivascular cells (including CAR cells) and 
BM adipocytes post-natally (33, 35, 37). The lack of a bone phenotype in Osx1:RargΔ/Δ mice 
suggests that the bone defects following deletion of Rarg are not due to lack of Rarg in cells 
committed to the osteoblast lineage.  Thus, the regulation of bone length and trabecular bone 
mass via RARγ activity appears to occur in MSCs (or potentially their immature progeny). 
Deletion of RARs using Col2a1-Cre, which targets chondrocytes, osteoblasts and synovial 
fibroblasts (38, 39), has also been shown to alter endochondral bone growth (29). Col2a1-
Cre+:Rarafl/flRargfl/fl mice and Col2a1-Cre+:Rarbfl/flRargfl/fl mice were reported to have low 
trabecular bone mass, but this was not quantitated (29), so we cannot reliably compare that 
aspect of the phenotype to our models. However, Col2a1-Cre+:Rarafl/flRargfl/fl mice and 
Col2a1-Cre+:Rarbfl/flRargfl/fl mice, but not Col2a1-Cre+:Rarafl/flRarbfl/fl mice had narrow 
growth plates and exhibited impaired long bone growth (29). In the growth plates of these mice 
the hypertrophic zone appeared largely unaffected, but chondrocyte proliferation was impaired. 
This aberrant functioning of the growth plate impaired endochondral bone formation, resulting 
in a lower trabecular bone mass in Col2a1-Cre+:Rarafl/flRargfl/fl mice and Col2a1-
Cre+:Rarbfl/flRargfl/fl mice. The bone phenotype of Col2a1-Cre+:Rargfl/fl mice was not 
assessed, however, given that mice lacking Rara and Rarb in Col2a1-Cre-targeted 
chondrocytes appeared phenotypically normal, loss of RARγ is likely to be the main 
contributor to the phenotypes observed in the Col2a1-Cre+:Rarafl/flRargfl/fl and Col2a1-
Cre+:Rarbfl/flRargfl/fl mice.   
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If Rarg expression in differentiating chondrocytes is required for normal growth plate function 
and subsequent endochondral bone formation and long bone growth, this could contribute to 
both the trabecular bone and longitudinal growth defects observed in Prrx1:RargΔ/Δ mice, 
because chondrocytes are targeted by Prrx1. Indeed, in Prrx1:RargΔ/Δ mice the growth plate 
showed early abnormalities in hypertrophy, and in adult bones was shorter than that of controls, 
suggesting a potential cause of the impaired longitudinal growth. Intriguingly, Prrx1:RargΔ/Δ 
mice also exhibited islands of hypertrophic chondrocytes trapped in the trabecular bone in the 
epiphysis of tibiae; this also suggests an extension of the hypertrophic stage. Cartilage remnants 
have similarly been observed in diaphyseal trabecular bone of Osx1-Cre:EphrinB2Δ/Δ mice and 
occur due to defective osteoclastic resorption in the primary ossification center (40). Similarly, 
children with osteogenesis imperfecta also contain cartilage within their bones after treatment 
with anti-resorptive bisphosphonate therapy (41). The presence of an extended hypertrophic 
zone at the growth plate, and hypertrophic chondrocyte islands in Prrx1:RargΔ/Δ mice thus 
suggests that chondrocyte hypertrophy may progress more slowly leading to impaired 
resorption of the secondary ossification center. 
One factor that plays a role in endochondral ossification and therefore long bone growth and 
trabecular bone formation is Vegf-a, which may contribute to the phenotype in Prrx1:RargΔ/Δ 
mice. Vegf-a plays an essential role in the neovascularization of cartilage, facilitating 
endochondral bone formation (42, 43). In the BM, Vegf-a is expressed by osteoblast-lineage 
cells, hypertrophic chondrocytes and some proliferating chondrocytes (42, 44), and some 
hematopoietic cells, including myeloid progenitors and megakaryocytes (45). Vegf-a 
stimulates the recruitment of endothelial cells for vessel formation, which in turn recruits 
osteoclasts and osteoblasts to the growth plate to resorb and replace cartilage with mineralized 
bone (46).  As expected, the increased Vegfa expression in the BM Prrx1:RargΔ/Δ female mice 
was accompanied by significantly more sinusoidal vessels in the BM secondary spongiosa, 
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however, the sinusoids were constricted, resulting in significantly reduced overall vessel area 
in the BM compared to Prrx1:Rarg+/+ mice. This gain of function effect is the opposite of, and 
hence consistent with, reports of mice lacking 2 of the 3 VEGF isoforms; VEGF164 and 
VEGF188, but still expressing VEGF120. These mice have fewer, more dilated blood vessels, 
indicating that the VEGF164 and VEGF188 isoforms are essential for BM vascularization (47). 
The sinusoidal vessels were similarly constricted in male Prrx1:RargΔ/Δ mice, however the 
vessel number was not increased. The normal number of sinusoidal vessels in the males may 
indicate that the excess Vegf-a is acting elsewhere in the BM. Furthermore, given Vegfa 
expression was unchanged in Prrx1:RargΔ/Δ MSCs and osteoblast-lineage cells isolated from 
collagenase-digested bone, the increased Vegfa in the BM must be derived from an alternate 
cell type. Indeed, our studies revealed that Vegf-a was upregulated in the megakaryocytes in 
the bone marrow of the Prrx1:RargΔ/Δ mice. Megakaryocytes and megakaryocyte cell lines 
have previously been shown to produce and secrete VEGF (48, 49). It is currently unclear as 
to why Vegf-a was increased in the megakaryocytes of Prrx1:RargΔ/Δ mice. However, the 
increased Vegf-a observed throughout the bone marrow correlated with the vascular changes 
we observed throughout the BM, whereas localized disruption to Vegf-a expression in 
chondrocytes of mice lacking leukemia inhibitory factor (LIF) results in enhanced 
vascularization localized to the growth plate (32). 
Vegf-a also has direct effects on osteoclast precursors, increasing their expression of RANK 
(50) and enhancing osteoclastic differentiation, survival and resorptive activity (51). 
Furthermore, Gerber et al. found that inhibition of Vegf-a signaling in 24-day-old mice 
impaired vascularization and cartilage resorption (44). Thus in Prrx1:RargΔ/Δ males, it is likely 
that the increase in Vegfa contributed to the elevated trabecular osteoclasts and lower trabecular 
bone mass through the stimulation of osteoclast differentiation and recruitment, stimulation of 
cartilage and bone resorption, and/or prolonging the survival of trabecular osteoclasts. This 
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was consistent with the reduction in trabecular number accompanied by increased trabecular 
spacing but unaltered trabecular thickness in the Prrx1:RargΔ/Δ male mice, which is indicative 
of enhanced resorption. While the osteoclast numbers were unchanged in Prrx1:RargΔ/Δ 
females, the enhanced vascularization may have increased the osteoblast recruitment to the 
bone surface, contributing to the increased numbers of osteoblasts observed in these female 
mice.  
Prrx1:RargΔ/Δ male mice also displayed altered B lymphopoiesis, indicating that RARγ 
signaling in Prrx1-Cre-targeted cells and/or their progeny are important BM 
microenvironment regulators of B lymphopoiesis. Male Prrx1:RargΔ/Δ mice had increased 
numbers of B lymphocyte precursors in the BM, with elevated pro-B and pre-B lymphocytes, 
but no changes in the more primitive pre-pro-B lymphocytes. Interestingly, the increase in 
immature B lymphocyte numbers were not reflected in mature B lymphocyte populations, 
because the numbers of immature B220+IgM+ B lymphocytes, splenic and mature PB B 
lymphocytes were unchanged.  
The upregulated Cxcl12 expression in Prrx1:RargΔ/Δ male BM was consistent with the B 
lymphocyte phenotype observed in these mice. Cxcl12 is a positive regulator of B 
lymphopoiesis from the pre-pro-B to pre-B cell stages, hence could be contributing to the 
increased numbers of pro-B and pre-B lymphocytes observed in Prrx1:RargΔ/Δ male mice.  The 
BM is the site of early B lymphopoiesis and distinct niches regulate different stages of 
development, including osteoblasts, osteoclasts, CAR cells, IL-7-expressing cells and 
endothelial cells. MSCs and osteoblast lineage cells play important roles in regulating early B 
lymphopoiesis (31). To determine if the increased expression of Cxcl12, or other potential B 
lymphocyte regulators, originated in Prrx1-derived mesenchymal cells, we FACS-isolated 
populations of MSCs (Sca-1+, CD51+) and osteoblast-lineage cells (Sca-1-, CD51+) from bone 
and examined their expression of known key B lymphocyte regulators. Surprisingly, many 
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regulatory genes were reduced in both MSCs (e.g. Cxcl12, Kitl and Flt3) and osteoblast-lineage 
cells (e.g. Cxcl12, Kitl and Il7), despite pro-B and pre-B cells being higher in Prrx1:RargΔ/Δ 
mice. This is the opposite to what we would expect if these cell types were regulating B 
lymphopoiesis in Prrx1:RargΔ/Δ mice as they are all identified as positive regulators of early B 
lymphopoiesis (31, 33, 52-55). This implies that other cell type(s) in the BM microenvironment 
are responsible for the increased B lymphocyte phenotype in these mice. These cells are likely 
to be the source of the increased Cxcl12 expression in the BM in Prrx1:RargΔ/Δ male mice. 
Some candidates are chondrocytes (56) and endothelial cells (33), which have both been shown 
to express Cxcl12. 
Another possible contributor to the increased pro-B and pre-B cells in the male Prrx1:RargΔ/Δ 
mice was the increased osteoclasts observed in these mice (31). Blin-Wakkach et al. showed 
that osteopetrotic oc/oc mice had impaired production of BM B lymphocytes from the pro-B 
cell stage (57) that was rescued by transplanting normal BM containing osteoclast precursors 
(58). Furthermore, administration of the anti-resorptive zoledronic acid (ZA) led to impaired 
B lymphopoiesis from the pre-pro-B lymphocyte stage, with no direct effect of ZA observed 
on the B lymphocyte cells (58). ZA treatment also dramatically reduced Cxcl12 and Il7 
expression in CD45- BM cells, which are devoid of most hematopoietic cells (58). Thus, altered 
osteoclast function modifies the regulation of B lymphopoiesis in the bone marrow (31). This 
is complementary to our studies showing that Prrx1:RargΔ/Δ male, but not female, mice had 
increased osteoclastogenesis and increased pro-B and pre-B lymphocyte numbers, suggesting 
that enhanced osteoclastogenesis may contribute to the B lymphocyte phenotype. 
The increase in B lymphocyte precursors in male Prrx1:RargΔ/Δ mice (Fig. 6) contrasts to the 
reduced pre-B lymphocytes observed in male Rarg-/- and nestin-Cre+:RargΔ/Δ mice, reduced 
pro-B cells in Rarg-/- mice and unchanged pro-B cells in nestin-Cre+:RargΔ/Δ mice (9). 
Furthermore, Osx1:RargΔ/Δ mice had no alterations in the numbers of B lymphocytes in their 
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BM, spleen or PB (9). Prrx1- and nestin-expressing cells are distinct, non-overlapping 
populations in the BM, targeting limb bud and neural crest mesenchyme, respectively (9, 33, 
59). As such, RARγ signaling appears to differentially regulate B lymphopoiesis in Prrx1- and 
nestin-Cre-targeted cells and these cells may form distinct B lymphocyte niches.  
In this study, we identified that RARγ signaling in Prrx1-Cre-targeted mesenchymal cells is 
required for BM microenvironment development. Loss of Rarg in Prrx1-Cre-targeted cells 
impaired tibial longitudinal growth and caused a lower trabecular bone mass, however, the 
normal bone phenotype in Osx1:RargΔ/Δ mice suggested that this was not due to loss of Rarg 
in osteoblast progenitors or osteoblasts. Prrx1:RargΔ/Δ mice also exhibited a smaller growth 
plate, retained hypertrophic chondrocytes in epiphyseal trabecular bone and had defective 
endochondral bone formation with increased angiogenesis and altered trabecular 
osteoclastogenesis (in males) and osteoblastogenesis (in females). Furthermore, the increased 
osteoclastogenesis observed in Prrx1:RargΔ/Δ males was accompanied by increased numbers 
of pro-B and pre-B lymphocytes in the male mice, suggesting another link between osteoclasts 
and B lymphocytes. Collectively, our data identify that in limb bud-derived MSCs, RARg is a 
key direct regulator of endochondral bone formation, and is an extrinsic regulator of 
angiogenesis, osteoclastogenesis and immature B lymphopoiesis in the bone marrow. 
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Figure 1: Rarg-/- mice have less trabecular bone and shorter tibiae than Rarg+/+ mice 
Tibial trabecular bone structure and length was analyzed by µCT in 12-week-old male and 
female Rarg+/+ vs. Rarg-/- mice. The graphs show trabecular bone volume (BV/TV; A), 
trabecular thickness (Tb.Th; B), trabecular separation (Tb.Sp; C) and trabecular number (Tb.N; 
D). Representative reconstructed tibiae images for male (E-F) and female (G-H) mice. Graph 
(I) shows tibial lengths for 12-week-old mice. Male (n=10), female Rarg+/+ (n=8) and Rarg-/- 
(n=6) mice. **p<0.01, ***p<0.001 and ****p<0.0001 (unpaired two-tailed Student’s t-test).  
Figure 2: Rarg-/- mice have thinner cortical bone and narrower tibiae than Rarg+/+ mice 
Tibial cortical bone structure was analyzed by µCT in 12-week-old male and female Rarg+/+ 
vs. Rarg-/- mice. The graphs show cortical bone thickness (Ct.Th; A), marrow area (Ma.Ar; B), 
cortical area (Ct.Ar; C) and periosteal perimeter (Ps.Pm; D). Males (n=10), female Rarg+/+ 
(n=8) and Rarg-/- (n=6) mice. **p<0.01, ***p<0.001 and ****p<0.0001 (unpaired two-tailed 
Student’s t-test).  
Figure 3: 12-week-old Osx1:RargΔ/Δ mice do not exhibit a defect in trabecular bone 
Tibial trabecular bone structure was analyzed by µCT in 12-week-old male Osx1:Rarg+/+ (n=7) 
vs. Osx1:RargΔ/Δ (n=12) mice. The graphs show trabecular bone volume (BV/TV; A), 
trabecular thickness (Tb.Th; B), trabecular separation (Tb.Sp; C) and trabecular number (Tb.N; 
D). Representative reconstructed images of trabecular bone are shown for Osx1:Rarg+/+ (E) 
and Osx1:RargΔ/Δ (F). *p<0.05, **p<0.01, and ***p<0.001 (unpaired two-tailed Student’s t-
test). 
Figure 4: Prrx1:RargΔ/Δ mice have less trabecular bone than Prrx1:Rarg+/+ mice 
Tibial trabecular bone structure was analyzed by µCT in 12-week-old male and female 
Prrx1:Rarg+/+ vs. Prrx1:RargΔ/Δ mice. The graphs show trabecular bone volume (BV/TV; A), 
trabecular thickness (Tb.Th; B), trabecular separation (Tb.Sp; C), trabecular number (Tb.N; D) 
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and tibial length (I). Representative reconstructed images of trabecular bone are shown for 
males (E-F) and females (G-H). Male Prrx1:Rarg+/+ (n=11), Prrx1:RargΔ/Δ (n=12), female 
Prrx1:Rarg+/+ (n=13) and Prrx1:RargΔ/Δ (n=15) mice. *p<0.05, **p<0.01, and ***p<0.001 
(unpaired two-tailed Student’s t-test).  
 
Figure 5: Prrx1:RargΔ/Δ male mice have greater osteoclastogenesis and females have more 
osteoid surface and osteoblasts compared to Prrx1:Rarg+/+ mice 
Histomorphometry of the tibial secondary spongiosa was performed on non-decalcified plastic 
embedded bones (A-G), and decalcified paraffin embedded bones (H-L). The graphs show the 
osteoid volume/bone volume (OV/BV; A), osteoid surface/bone surface (OS/BS; B), osteoid 
thickness (O.Th; C), osteoblast surface/bone surface (Ob.S/BS; D), number of osteoblasts/bone 
perimeter (N.Ob/B.Pm; E), osteoclast surface/ bone surface (Oc.S/BS; F) and number of 
osteoclasts/bone perimeter (N.Oc/B.Pm; G). Male Prrx1:Rarg+/+ (n=9), Prrx1:RargΔ/Δ (n=10), 
female Prrx1:Rarg+/+ (n=8) and Prrx1:RargΔ/Δ (n=10) mice. Graph (H) shows the number of 
hypertrophic chondrocyte islands in epiphyseal bone, representative images (I-K) of male 
Prrx1:Rarg+/+ (I) and Prrx1:RargΔ/Δ (J-K) tibiae showing chondrocyte islands (black 
arrowheads) and graph (L) shows growth plate width in tibiae; scale bars are 500 µm (I-J) and 
100 µm (K). Graph (M) shows the width of the proliferative zone and graph (N) shows 
the width of the hypertrophic zone in 20-day old tibiae, representative images (O, P) of 
male Prrx1:Rarg+/+ (O) and Prrx1:RargΔ/Δ (P) tibiae. HZ= hypertrophic zone, PZ= 
proliferative zone, GZ= germinal zone. Male Prrx1:Rarg+/+ (n=7), Prrx1:RargΔ/Δ (n=6), 
female Prrx1:Rarg+/+ (n=6) and Prrx1:RargΔ/Δ (n=9) mice. *p<0.05, **p<0.01 and 
***p<0.001 (unpaired two-tailed Student’s t-test).  
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Figure 6: Prrx1:RargΔ/Δ male mice have increased pro-B and pre-B lymphocytes in the 
bone marrow compared to Prrx1:Rarg+/+ male mice 
Graph (A) shows the number of bone marrow (BM) leukocytes per femur in Prrx1:Rarg+/+ 
and Prrx1:RargΔ/Δ mice. Representative flow cytometry plots of B lymphocytes subsets (B-C). 
The graphs show the numbers of cells per femur for: B220+IgM- and B220+IgM+ B 
lymphocytes (D), CD19-CD43- pre-pro-B lymphocytes, CD19+CD43+ pro-B lymphocytes and 
CD19+CD43- pre-B lymphocytes (E). Male Prrx1:Rarg+/+ (n=10), Prrx1:RargΔ/Δ (n=12), 
female Prrx1:Rarg+/+ (n=13) and Prrx1:RargΔ/Δ (n=12) mice. Schematic (I) shows stages of B 
lymphopoiesis highlighting pro-B and pre-B stages altered in Prrx1:RargΔ/Δ males; 
hematopoietic stem cell (HSC), common lymphoid progenitor (CLP). qPCR of Cxcl12 (G), 
Flt3l (H), Tnfrsf11b (I) and Vegfa (J) gene expression in whole BM cells from Prrx1:Rarg+/+ 
and Prrx1:RargΔ/Δ male mice (n=4 mice/group). The expression of these transcripts, including 
secreted (sec) and membrane-bound (mem) forms of Kitl are also shown in FACS-sorted MSCs 
(K) and osteoblast lineage cells (L) obtained from Prrx1:RargΔ/Δ male mice, with expression 
normalized to cells sorted from Prrx1:Rarg+/+ male mice (n=3-5 separate experiments/group). 
*p<0.05, **p<0.01, and ***p<0.001 (unpaired two-tailed Student’s t-test).  
 
Figure 7: Prrx1:RargΔ/Δ mice have smaller BM sinusoidal vessels and females have more 
sinusoids and increased Vegf-a expression in megakaryocytes 
Immunohistochemistry of VEGFR-3+ sinusoidal vessels in the secondary spongiosa of 
Prrx1:Rarg+/+ and Prrx1:RargΔ/Δ mice. The graphs show the number of sinusoids/ marrow area 
(N.sinusoids/Ma.Ar; A), sinusoid area/ sinusoid (Sinusoid.Ar/sinusoid; B), sinusoid area/ 
marrow area (sinusoid Ar/Ma.Ar; C), and sinusoid perimeter/ marrow area (sinusoid 
Pm./Ma.Ar; D). Representative images (E-H) of VEGFR-3-stained BM sections, showing 
sinusoids (s), bone marrow (bm) and trabecular bone (tb), scale bars are 100 µm. 
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Representative images showing EYFP and Vegf-a stained BM sections obtained from (I) 
Prrx1:Rarg+/+ and (J) Prrx1:RargΔ/Δ mice. The images show growth plate and bone 
marrow regions separately, with enlargements of each region in the insets. Scale bars are 
100 µm. (K) Flow cytometry quantitation of the proportion of CD41+ megakaryocytes in 
the BM of Prrx1:Rarg+/+ and Prrx1:RargΔ/Δ mice. Male Prrx1:Rarg+/+ (n=8), Prrx1:RargΔ/Δ 
(n=8), female Prrx1:Rarg+/+ (n=8) and Prrx1:RargΔ/Δ (n=9) mice. *p<0.05 and *p<0.05 
(unpaired two-tailed Student’s t-test). 







